Literature DB >> 28147419

Somatosensory Evoked Potentials in Patients with Hypoxic-Ischemic Brain Injury.

Janneke Horn1, Marleen C Tjepkema-Cloostermans2.   

Abstract

Predicting the future of patients with hypoxic-ischemic encephalopathy after successful cardiopulmonary resuscitation is often difficult. Registration of the median nerve somatosensory evoked potential (SSEP) can assist in the neurologic evaluation in these patients. In this article, the authors discuss the principles, applications, and limitations of SSEP registration in the intensive care unit, with a focus on prognostication. Registration of the SSEP is a very reliable and reproducible method, if it is performed and interpreted correctly. During SSEP recordings, great care should be taken to improve the signal-to-noise ratio. If the noise level is too high, the peripheral responses are abnormal or the response is not reproducible in a second set of stimuli; therefore, interpretation of the SSEPs cannot be done reliably. A bilaterally absent cortical SSEP response is a very reliable predictor of poor neurologic outcome in patients with HIE. It has a high specificity, but a low sensitivity, indicating that present cortical responses are a weak predictor of a good recovery. Further research is being done to increase the sensitivity. Somatosensory evoked potentials can be used in a multimodal approach for prognostication of outcome. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2017        PMID: 28147419     DOI: 10.1055/s-0036-1594252

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  8 in total

Review 1.  Prognostication of patients after cardiopulmonary resuscitation.

Authors:  M J Jackson; A S Mockridge
Journal:  BJA Educ       Date:  2018-03-03

2.  European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care.

Authors:  Jerry P Nolan; Claudio Sandroni; Bernd W Böttiger; Alain Cariou; Tobias Cronberg; Hans Friberg; Cornelia Genbrugge; Kirstie Haywood; Gisela Lilja; Véronique R M Moulaert; Nikolaos Nikolaou; Theresa Mariero Olasveengen; Markus B Skrifvars; Fabio Taccone; Jasmeet Soar
Journal:  Intensive Care Med       Date:  2021-03-25       Impact factor: 17.440

Review 3.  Neurophysiology contributes to outcome prediction after cardiac arrest.

Authors:  Nick Kane; Larry Robinson; Jerry P Nolan
Journal:  Clin Neurophysiol Pract       Date:  2017-09-29

Review 4.  SSEP retains its value as predictor of poor outcome following cardiac arrest in the era of therapeutic hypothermia.

Authors:  Ted L Rothstein
Journal:  Crit Care       Date:  2019-10-23       Impact factor: 9.097

Review 5.  Brain injury after cardiac arrest: pathophysiology, treatment, and prognosis.

Authors:  Claudio Sandroni; Tobias Cronberg; Mypinder Sekhon
Journal:  Intensive Care Med       Date:  2021-10-27       Impact factor: 17.440

6.  Serum tau and neurological outcome in cardiac arrest.

Authors:  Niklas Mattsson; Henrik Zetterberg; Niklas Nielsen; Kaj Blennow; Josef Dankiewicz; Hans Friberg; Gisela Lilja; Philip S Insel; Christian Rylander; Pascal Stammet; Anders Aneman; Christian Hassager; Jesper Kjaergaard; Michael Kuiper; Tommaso Pellis; Jørn Wetterslev; Matthew Wise; Tobias Cronberg
Journal:  Ann Neurol       Date:  2017-11-02       Impact factor: 10.422

Review 7.  Targeted Temperature Management and Multimodality Monitoring of Comatose Patients After Cardiac Arrest.

Authors:  Peggy L Nguyen; Laith Alreshaid; Roy A Poblete; Geoffrey Konye; Jonathan Marehbian; Gene Sung
Journal:  Front Neurol       Date:  2018-09-11       Impact factor: 4.003

8.  Multimodal Long-Term Predictors of Outcome in Out of Hospital Cardiac Arrest Patients Treated with Targeted Temperature Management at 36 °C.

Authors:  Erik Roman-Pognuz; Jonathan Elmer; Frank X Guyette; Gabriele Poillucci; Umberto Lucangelo; Giorgio Berlot; Paolo Manganotti; Alberto Peratoner; Tommaso Pellis; Fabio Taccone; Clifton Callaway
Journal:  J Clin Med       Date:  2021-03-23       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.